Generex Presents New Positive AE37 Phase II Breast Cancer Vaccine Data [Archive]

View Full Version : Generex Presents New Positive AE37 Phase II Breast Cancer Vaccine Data

News

12-07-2010, 07:10 AM

Generex Biotechnology Corporation (OTC Bulletin Board: GNBT) announced two presentations of data obtained from its on-going Phase II trial of its novel immunotherapeutic AE37 vaccine in breast cancer patients...

More... (http://mnt.to/f/3NG2)